37 CFR 1.52 — Language, paper, writing, margins, read-only optical disc specifications
Ninth Edition, Revision 01.2024
- (a)
Papers that are to become a part of the permanent
United States Patent and Trademark Office records in the file
of a patent application, or a reexamination or supplemental
examination proceeding.
- (1) All papers, other than drawings, that are
submitted on paper or by facsimile transmission, and are to
become a part of the permanent United States Patent and
Trademark Office records in the file of a patent application
or reexamination or supplemental examination proceeding, must
be on sheets of paper that are the same size, not permanently
bound together, and:
- (i) Flexible, strong, smooth, non-shiny, durable, and white;
- (ii) Either 21.0 cm by 29.7 cm (DIN size A4) or 21.6 cm by 27.9 cm (8 1/2 by 11 inches), with each sheet including a top margin of at least 2.0 cm (3/4 inch), a left side margin of at least 2.5 cm (1 inch), a right side margin of at least 2.0 cm (3/4 inch), and a bottom margin of at least 2.0 cm (3/4 inch);
- (iii) Written on only one side in portrait orientation;
- (iv) Plainly and legibly written either by a typewriter or machine printer in permanent dark ink or its equivalent; and
- (v) Presented in a form having sufficient clarity and contrast between the paper and the writing thereon to permit the direct reproduction of readily legible copies in any number by use of photographic, electrostatic, photo-offset, and microfilming processes and electronic capture by use of digital imaging and optical character recognition.
- (2) All papers that are submitted on paper or by facsimile transmission and are to become a part of the permanent records of the United States Patent and Trademark Office should have no holes in the sheets as submitted.
- (3) The provisions of this paragraph and paragraph (b) of this section do not apply to the pre‑printed information on paper forms provided by the Office, or to the copy of the patent submitted on paper in double column format as the specification in a reissue application or request for reexamination.
- (4) See § 1.58 for chemical and mathematical formulae and tables, and § 1.84 for drawings.
- (5) Papers that are submitted electronically to the Office must be formatted and transmitted in compliance with the USPTO patent electronic filing system requirements.
- (1) All papers, other than drawings, that are
submitted on paper or by facsimile transmission, and are to
become a part of the permanent United States Patent and
Trademark Office records in the file of a patent application
or reexamination or supplemental examination proceeding, must
be on sheets of paper that are the same size, not permanently
bound together, and:
- (b)
The application (specification, including the claims,
drawings, and the inventor’s oath or declaration) or
reexamination or supplemental examination proceeding, any
amendments to the application or reexamination proceeding, or
any corrections to the application, or reexamination or
supplemental examination proceeding.
- (1) The application or proceeding and any
amendments or corrections to the application (including any
translation submitted pursuant to paragraph (d) of this
section) or proceeding, except as provided for in §
1.69
and
paragraph (d) of this section, must:
- (i) Comply with the requirements of paragraph (a) of this section; and
- (ii) Be in the English language or be accompanied by a translation of the application and a translation of any corrections or amendments into the English language together with a statement that the translation is accurate.
- (2) The specification (including the abstract
and claims) for other than reissue applications and
reexamination or supplemental examination proceedings, and
any amendments for applications (including reissue
applications) and reexamination proceedings to the
specification, except as provided for in §§
1.821
through
1.825
, must have:
- (i) Lines that are 1 1/2 or double spaced;
- (ii) Text written in a nonscript type font ( e.g., Arial, Times Roman, or Courier, preferably a font size of 12) lettering style having capital letters which should be at least 0.3175 cm. (0.125 inch) high, but may be no smaller than 0.21 cm. (0.08 inch) high ( e.g., a font size of 6); and
- (iii) Only a single column of text.
- (3) The claim or claims must commence on a separate physical sheet or electronic page (§ 1.75(h) ).
- (4) The abstract must commence on a separate physical sheet or electronic page or be submitted as the first page of the patent in a reissue application or reexamination or supplemental examination proceeding (§ 1.72(b) ).
- (5) Other than in a reissue application or a reexamination or supplemental examination proceeding, the pages of the specification including claims and abstract must be numbered consecutively, starting with 1, the numbers being centrally located above or preferably, below, the text.
- (6) Other than in a reissue application or reexamination or supplemental examination proceeding, the paragraphs of the specification, other than in the claims or abstract, may be numbered at the time the application is filed, and should be individually and consecutively numbered using Arabic numerals, so as to unambiguously identify each paragraph. The number should consist of at least four numerals enclosed in square brackets, including leading zeros ( e.g., [0001]). The numbers and enclosing brackets should appear to the right of the left margin as the first item in each paragraph, before the first word of the paragraph, and should be highlighted in bold. A gap, equivalent to approximately four spaces, should follow the number. Nontext elements ( e.g., tables, mathematical or chemical formulae, chemical structures, and sequence data) are considered part of the numbered paragraph around or above the elements, and should not be independently numbered. If a nontext element extends to the left margin, it should not be numbered as a separate and independent paragraph. A list is also treated as part of the paragraph around or above the list, and should not be independently numbered. Paragraph or section headers (titles), whether abutting the left margin or centered on the page, are not considered paragraphs and should not be numbered.
- (1) The application or proceeding and any
amendments or corrections to the application (including any
translation submitted pursuant to paragraph (d) of this
section) or proceeding, except as provided for in §
1.69
and
paragraph (d) of this section, must:
- (c) Interlineation, erasure, cancellation, or other alteration of the application papers may be made before or after the signing of the inventor’s oath or declaration referring to those application papers, provided that the statements in the inventor’s oath or declaration pursuant to § 1.63 remain applicable to those application papers. A substitute specification (§ 1.125 ) may be required if the application papers do not comply with paragraphs (a) and (b) of this section.
- (d) A nonprovisional or provisional application under
35 U.S.C. 111
may be in a language other than English.
- (1) Nonprovisional application. If a nonprovisional application under 35 U.S.C. 111(a) is filed in a language other than English, an English language translation of the non-English language application, a statement that the translation is accurate, and the processing fee set forth in § 1.17(i) are required. If these items are not filed with the application, the applicant will be notified and given a period of time within which they must be filed in order to avoid abandonment.
- (2) Provisional application. If a provisional application under 35 U.S.C. 111(b) is filed in a language other than English, an English language translation of the non-English language provisional application will not be required in the provisional application. See § 1.78(a) for the requirements for claiming the benefit of such provisional application in a nonprovisional application.
- (e)
Electronic documents submitted on a read-only optical disc
that are to become part of the permanent United States Patent
and Trademark Office records in the file of a patent
application, reexamination, or supplemental examination
proceeding.
- (1) The following documents may be submitted to
the Office on a read-only optical disc in compliance with
this paragraph (e):
- (i) A “Computer Program Listing Appendix” ( see § 1.96(c) );
- (ii) A “Sequence Listing” (submitted under § 1.821(c) in compliance with §§ 1.822 through 1.824 ) or a “Sequence Listing XML” (submitted under § 1.831(a) in compliance with §§ 1.832 through 1.834 ); or
- (iii) “Large Tables” ( see § 1.58(c) ).
- (2) Read-only optical disc as used in this part
means a finalized disc, in conformance with International
Organization for Standardization (ISO) 9660, on which the
data is recorded so it is permanent and cannot be changed or
erased, and is one of:
- (i) Compact Disc-Read-Only Memory (CD–ROM) or a Compact Disc-Recordable (CD–R); or
- (ii) Digital Video Disc-Recordable (DVD–R or DVD+R);
- (3) Each read-only optical disc must
conform to the following requirements:
- (i) Computer compatibility: PC or Mac ®;
- (ii) Operating system compatibility: MS–DOS ®, MS–Windows ®, MacOS ®, or Unix ®/Linux ®;
- (iii) The contents of each read-only optical disc must be in American Standard Code for Information Interchange (ASCII) plain text and if compressed, must be compressed in accordance with § 1.58 for “Large Tables,” with § 1.96 for a “Computer Program Listing Appendix,” or § 1.824 for a “Sequence Listing” or Computer Readable Form (CRF) of the “Sequence Listing,” as applicable; and
- (iv) The contents of each read-only optical disc for a “Sequence Listing XML” must be in eXtensible Markup Language (XML) file format, and if compressed, must be compressed in accordance with § 1.834 .
- (4) Each read-only optical disc must be enclosed
in a hard case within an unsealed, padded, and protective
mailing envelope, and must be accompanied by a transmittal
letter in accordance with paragraph (a) of this section,
including the following information:
- (i) First-named inventor (if known);
- (ii) Title of the invention;
- (iii) Attorney docket or file reference number (if applicable);
- (iv) Application number and filing date (if known);
- (v) The operating system (MS–DOS ®, MS-Windows ®, Mac OS ®, or Unix ®/ Linux ®) used to produce the disc; and
- (vi) The file(s) contained on the read-only optical disc, including the name of the file, the size of the file in bytes, and the date of creation.
- (5) Each read-only optical disc must have a
label permanently affixed thereto on which the following
information has been hand-printed or typed:
- (i) First-named inventor (if known);
- (ii) Title of the invention;
- (iii) Attorney docket or file reference number (if applicable);
- (iv) Application number and filing date (if known);
- (v) Date on which the data were recorded on the read-only optical disc; and
- (vi) Disc order ( e.g., “1 of X”), if multiple read-only optical discs are submitted.
- (6) Read-only optical discs will not be returned to the applicant and may not be retained as part of the patent application file.
- (7) Any amendment to the information on a read-only optical disc must be by way of a replacement read-only optical disc, in compliance with § 1.58(g) for “Large Tables,” § 1.96(c)(5) for a “Computer Program Listing Appendix,” § 1.825(b) for a “Sequence Listing” or CRF of a “Sequence Listing,” and § 1.835(b) for a “Sequence Listing XML.”
- (8) The specification must contain an incorporation by reference of the material on each read-only optical disc in a separate paragraph (§ 1.77(b)(5) ), identifying the name of each file, their date of creation, and their size in bytes, except for an international application in the international stage. The Office may require the applicant to amend the specification to include the material incorporated by reference.
- (9) If a file is unreadable, it will be treated as not having been submitted, and a notice will be issued to require a compliant submission.
- (1) The following documents may be submitted to
the Office on a read-only optical disc in compliance with
this paragraph (e):
- (f)
Determining application size
fees for applications containing electronic documents submitted
on a read-only optical disc or via the USPTO patent electronic
filing system—
- (1) Submission on read-only optical discs. The application size fee required by § 1.16(s) or § 1.492(j) , for an application component submitted in part on a read-only optical disc in compliance with paragraph (e) of this section, shall be determined such that each three kilobytes of content submitted on a read-only optical disc shall be counted as a sheet of paper. Excluded from this determination is any ASCII plain text file or any XML file (as applicable) submitted on a read-only optical disc under paragraph (e) of this section containing:
- (2)
Submission via the USPTO patent electronic filing
system.
The application size fee required by §
1.16(s)
or §
1.492(j)
,
for an application submitted in whole or in part via the
USPTO patent electronic filing system, shall be determined
such that the paper size equivalent will be considered to be
75% of the number of sheets of paper present in the
specification and drawings for the application when entered
into the Office records after being rendered by the USPTO
patent electronic filing system. Excluded from this
determination is any ASCII plain text file or any XML file
(as applicable) submitted via the USPTO patent electronic
filing system containing:
- (i) Any “Sequence Listing” or CRF of a “Sequence Listing” in compliance with § 1.821(c)(1) or (e) , or any “Sequence Listing XML” in compliance with § 1.831(a) ; or
- (ii) Any “Computer Program Listing Appendix” in compliance with § 1.96(c) .
- (3) Oversized submission. Any submission of a “Sequence Listing” in electronic form or a “Sequence Listing XML” of 300 MB–800 MB filed in an application under 35 U.S.C. 111 or 371 will be subject to the fee set forth in § 1.21(o)(1) . Any submission of a “Sequence Listing” in electronic form or a “Sequence Listing XML” that exceeds 800 MB filed in an application under 35 U.S.C. 111 or 371 will be subject to the fee set forth in § 1.21(o)(2) .
[43 FR 20462, May 11, 1978; paras. (a) and (d), 47 FR 41272, Sept. 17, 1982, effective Oct. 1, 1982; para. (c), 48 FR 2696, Jan. 20, 1983, effective Feb. 27, 1983; para. (d), 49 FR 554, Jan. 4, 1984, effective Apr. 1, 1984; para. (c), 57 FR 2021, Jan. 17, 1992, effective Mar. 16, 1992; paras. (a) and (b) amended, 61 FR 42790, Aug. 19, 1996, effective Sept. 23, 1996; paras. (a), (c) & (d) revised, 62 FR 53132, Oct. 10, 1997, effective Dec. 1, 1997; para. (e) added, 65 FR 54604, Sept. 8, 2000, effective Sept. 8, 2000 (effective date corrected, 65 FR 78958, Dec. 18, 2000); paras. (a), (b), and (c) revised, 65 FR 54604, Sept. 8, 2000, effective Nov. 7, 2000; para. (d) revised, 65 FR 57024, Sept. 20, 2000, effective Nov. 29, 2000; paras. (a) and (b) revised, 68 FR 38611, June 30, 2003, effective July 30, 2003; section heading and paras. (b)(2)(ii), (e)(1)(iii) and (e)(3)(i)-(ii) revised, 69 FR 56481, Sept. 21, 2004, effective Oct. 21, 2004; section heading revised and para. (f) added; 70 FR 3880, Jan. 27, 2005, effective Dec. 8, 2004; para. (f) revised, 70 FR 30360, May 26, 2005, effective July 1, 2005; para. (e)(5) revised, 70 FR 54259, Sept. 14, 2005, effective Sept. 14, 2005; paras. (a)(5), (a)(7), and (b)(7) removed and para. (a)(6) redesignated as (a)(5), 70 FR 56119, Sept. 26, 2005, effective Nov. 25, 2005; para. (d)(2) revised, 72 FR 46716, Aug. 21, 2007 (implementation enjoined and never became effective); para. (d)(2) revised, 74 FR 52686, Oct. 14, 2009, effective Oct. 14, 2009 (to remove changes made by the final rules in 72 FR 46716 from the CFR); para. (b) heading and paras. (c) and (d) revised, 77 FR 48776, Aug. 14, 2012, effective Sept. 16, 2012; paras. (a), (b), and (e) revised, 78 FR 62368, Oct. 21, 2013, effective Dec. 18, 2013; paras. (e) and (f) revised, 86 FR 57035, Oct. 14, 2021, effective Nov. 15, 2021; paras. (e)(1)(ii), (e)(3)(ii) and (iii), (e)(7), (f)(1)(i), (f)(2)(i), and (f)(3) revised, para. (e)(3)(iv) added, and paras. (f)(1) and (f)(2) introductory text revised, 87 FR 30806, May 20, 2022, effective July 1, 2022; para. (a)(5) revised, 87 FR 68900, Nov. 17, 2022, effective Dec. 19, 2022]
Cited authority
- 37 CFR 1.58 Chemical and mathematical formulas and tables
- 37 CFR 1.84 Standards for drawings
- 37 CFR 1.69 Foreign language oaths and declarations
- 37 CFR 1.821 Nucleotide and/or amino acid sequence disclosures in patent applications
- 37 CFR 1.825 Amendments to add or replace a “Sequence Listing” and CRF copy thereof
- 37 CFR 1.75 Claim(s)
- 37 CFR 1.72 Title and abstract
- 37 CFR 1.63 Inventor’s oath or declaration
- 37 CFR 1.125 Substitute specification
- 35 U.S.C. 111 Application
- 37 CFR 1.17 Patent application and reexamination processing fees
- 37 CFR 1.78 Claiming benefit of earlier filing date and cross-references to other applications
- 37 CFR 1.96 Submission of computer program listings
- 37 CFR 1.822 Symbols and format to be used for nucleotide and/or amino acid sequence data
- 37 CFR 1.824 Form and format for a nucleotide and/or amino acid sequence submissions as an ASCII plain text file
- 37 CFR 1.831 Requirements for patent applications filed on or after July 1, 2022, having nucleotide and/or amino acid sequence disclosures
- 37 CFR 1.832 Representation of nucleotide and/or amino acid sequence data in the “Sequence Listing XML” part of a patent application filed on or after July 1, 2022
- 37 CFR 1.834 Form and format for nucleotide and/ or amino acid sequence submissions as the ‘‘Sequence Listing XML’’ in patent applications filed on or after July 1, 2022
- 37 CFR 1.835 Amendment to add or replace a “Sequence Listing XML” in patent applications filed on or after July 1, 2022
- 37 CFR 1.77 Arrangement of application elements
- 37 CFR 1.16 National application filing, search, and examination fees
- 37 CFR 1.492 National stage fees
- 35 U.S.C. 371 National stage: Commencement
- 37 CFR 1.21 Miscellaneous fees and charges
Cited by
- 1120 Eighteen-Month Publication of Patent Applications
- 1121 Content of a Patent Application Publication
- 1132 Requests for Redacted Publication
- 1410 Content of Reissue Application
- 1411 Form of Specification
- 1415 Reissue Application and Issue Fees
- 1893.03(e) Documents Received from the International Bureau and Placed in a U.S. National Stage Application File
- 2163.07 Amendments to Application Which Are Supported in the Original Description
- 2214 Content of Request for Ex Parte Reexamination Filed under 35 U.S.C. 302
- 2215 Fee for Requesting Ex Parte Reexamination under 35 U.S.C. 302
- 2234 Entry of Amendments
- 2250 Amendment by Patent Owner
- 2413.01(h) Language Dependent Free Text Qualifier Values in the English Language
- 2413.03 How to Submit the “Sequence Listing XML”
- 2414.04 Translation of “Sequence Listing XML” is Not an Amended “Sequence Listing XML” under 37 CFR 1.835(b)
- 2416 Form Paragraphs
- 2421.03 Notification of a Failure to Comply
- 2422 Nucleotide and/or Amino Acid Sequence Disclosures in Patent Applications Subject to WIPO ST.25
- 2422.03 Sequence Listing Submission
- 2422.03(a) “Sequence Listing” Submitted as ASCII Plain Text Files
- 2422.04 The Requirement for a Computer Readable Copy of the “Sequence Listing”
- 2422.06 Requirement for Statement Regarding Information Contained in the “Sequence Listing” and Separate Computer Readable Form
- 2424 Requirements for Content of a “Sequence Listing” Part of the Specification under WIPO ST.25.
- 2425 Form and Format for a Nucleotide and/or Amino Acid Sequence Submission as an ASCII Plain Text File under WIPO ST.25
- 2426 Amendments to Add or Replace a “Sequence Listing” and CRF Copy Thereof Subject to WIPO ST. 25
- 2427 Form Paragraphs for Applications Subject to WIPO ST.25
- 2429 Helpful Hints for Sequence Rules Compliance under WIPO ST.25
- 2433 Box Sequence; Hand Delivery of a “Sequence Listing” and Computer Readable Forms
- 2730 Applications Filed on or After May 29, 2000; Grounds for Adjustment
- 2732 Reduction of Period of Adjustment of Patent Term
- 2807 Format of Papers Filed in a Supplemental Examination Proceeding
- 2811 Content of Request for Supplemental Examination
- 502.02 Correspondence Signature Requirements
- 502.05 Correspondence Transmitted by EFS-Web
- 506 Completeness of Original Application
- 507 Drawing Review in the Office of Patent Application Processing
- 601 Content of Provisional and Nonprovisional Applications
- 601.05 Bibliographic Information - Application Data Sheet (ADS)
- 602.08(b) Inventor Signature and Name
- 607 Filing Fee
- 608.01 Specification
- 608.01(a) Arrangement of Application
- 608.01(b) Abstract of the Disclosure
- 608.01(m) Form of Claims
- 608.01(q) Substitute or Rewritten Specification
- 608.02 Drawing
- 608.03 Models, Exhibits, Specimens
- 608.03(a) Handling of Models, Exhibits, and Specimens
- 608.05 “Sequence Listing,” “Large Tables,” or “Computer Program Listing Appendix” Submitted in ASCII Plain Text or a “Sequence Listing XML” Submitted as XML File Text
- 608.05(a) Submission of a “Computer Program Listing Appendix”
- 608.05(b) ASCII Plain Text Submissions of “Large Tables” and Treatment of Lengthy Tables in a Specification for Patents and Patent Application Publications
- 609.04(a) Content Requirements for an Information Disclosure Statement
- 609.05(a) Noncomplying Information Disclosure Statements
- 708.02(a) Accelerated Examination
- 708.02(b) Prioritized Examination
- 714 Amendments, Applicant’s Action
- 714.01(e) Amendments Before First Office Action
- 714.07 Amendments Not in Permanent Ink
- 37 CFR 1.17 Patent application and reexamination processing fees
- 37 CFR 1.20 Post-issuance fees
- 37 CFR 1.58 Chemical and mathematical formulas and tables
- 37 CFR 1.77 Arrangement of application elements
- 37 CFR 1.91 Models or exhibits not generally admitted as part of application or patent
- 37 CFR 1.94 Return of models, exhibits or specimens
- 37 CFR 1.96 Submission of computer program listings
- 37 CFR 1.121 Manner of making amendments in applications
- 37 CFR 1.173 Reissue specification, drawings, and amendments
- 37 CFR 1.211 Publication of applications
- 37 CFR 1.217 Publication of a redacted copy of an application
- 37 CFR 1.530 Statement by patent owner in ex parte reexamination; amendment by patent owner in ex parte or inter partes reexamination; inventorship change in ex parte or inter partes reexamination
- 37 CFR 1.615 Format of papers filed in a supplemental examination proceeding
- 37 CFR 1.704 Reduction of period of adjustment of patent term
- 37 CFR 1.821 Nucleotide and/or amino acid sequence disclosures in patent applications
- 37 CFR 1.823 Requirements for content of a “Sequence Listing” part of the specification
- 37 CFR 1.824 Form and format for a nucleotide and/or amino acid sequence submissions as an ASCII plain text file
- 37 CFR 1.825 Amendments to add or replace a “Sequence Listing” and CRF copy thereof
- 37 CFR 1.833 Requirements for a “Sequence Listing XML” for nucleotide and/or amino acid sequences as part of a patent application filed on or after July 1, 2022
- 37 CFR 1.834 Form and format for nucleotide and/ or amino acid sequence submissions as the ‘‘Sequence Listing XML’’ in patent applications filed on or after July 1, 2022
- 37 CFR 1.943 Requirements of responses, written comments, and briefs in inter partes reexamination